<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 146 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page145.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=146">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 146 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 146</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=146"><img src="../thumb/146.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Cardio-Vascular Agents - 7.3.9                                                 2020-04 / 115
       Side effects: Symptomat.hypotens., angioed., GI disturbs., taste   reacts., vasculit., myalg., incr. bld.K, aplast.anaem, angle-clos.glauc.,   CO-IRBEWIN, Zentiva
       disturbs./loss thereof, urticar., rash, atypic.cutan.lymphoid infiltrat.,   erythema multiforme, asthen.  Irbesartan 150(300; 300) mg, hydrochlorothiazide 12,5(12,5; 25) mg
       palpitat., tachycard., back/leg/abdom./chest pain, musc. cramps, my-  Warnings and special precautions: Treatm.to be stopp.& chang.  Indications: Essent.hypertens.in pts.stabil.on same dos.of in-
       alg., headache, dizzin., insomn., migraine, cough, nas.congest., URTI,   should pregn.occur, consid. altern. meds.should a woman contempl.  div.compon.
       pharyngit., sinus disord., sev.ac.hepatotoxic., cholestas., bld. dyscras.,   pregn., dual blockade of the RAAS with ARBs/ ACE inhibits./ aliskiren.  300/25 mg tabs: Essent.hypertens.in pts.not adeq.contr.by
       ac. pancreatit., asthen., fatig., oed., imp. ren. funct., hyperkalaem.  assoc.with high.freq.of adv. vents, no rechalleng.aft.angioed.react.,   300/12,5 mg strength.
       Special precautions: Hepat.impairm., discont.if pregn.suspect.,   cross. placenta & excret.in breast milk, correct Na & vol. deplet. bef.  (S3) TABS, A40/7.1.3/0290, 0287.
                                             -
       adeq.contracept.for women of childbear. age, bil.ren.artery stenos.,   init.ther., concom.K-spar.diuret./-supplem./-salt substit./meds.incr.  712386-001: 150/12,5 mg, 28, R224,28
                                          +
                                     +
       artery stenos.to sngl.kidn., aort.valve stenos., hypertroph. obstruct.   K  lev., reg.K  / Na/ Mg/ ser.Li- monit., diab., mark.hypercalcaem.,   712386-002: 150/12,5 mg, 30, R240,18
       cardiomyopathy, teratogen.in animals, vol.deplet., monit.ser.K  conc.,   mild-mod.hepat.impairm.incl.obstruct.bil.disords., SLE exacerbat./  712387-001: 300/12,5 mg, 28, R224,28
                                +
       elderly, hepat. impairm., poss.ac.ren fail.  activat., gluc.tol.poss.alt., incr.in cholester., triglycer.& uric acid lev.,   712387-002: 300/12,5 mg, 30, R240,18
       Drug interactions: NSAID’s may antagon.eff., sympathomim.  monit.ren. funct of pts taking.concom.NSAIDs, poss.dos. adjustm.  Dosage: 1 tab.dly. If BP not adeq.control.another antihypertens.
                         +
                               +
       may reduc.eff., poss.hyperkalaem. with K -spar. diuret./K -contain.  of insul.& oral antidiab.,  may be add. Dos.high.than one 300/25 mg tab./day not recomm.
       meds.or K  supplem.           Interactions: Other antihypertens.drugs may incr. antihypertens.eff.,   Contraindications: Hypersens.to sulphonam.-deriv. drugs, anuric,
           +
                                     -
                                                        +
       CIPLAZAR, Cipla-Medpro [P/S]  K-spar.diuret./-supplem./-salt substit.may alt.K  lev., rev.incr.in ser. Li   angioed. hist.link.to prev.ACE inhibit./angiotens.recept.block, heredit./
                                                                  idiopath. angioed., hypertroph.obstruct.cardiomyopathy, sev.ren.funct.
                                     conc.& toxic. dur.concur.use, act.of curare derivat. potent., antihyper-
       Losartan potassium            tens. & diuret.eff.weak. by NSAID’s, system. expos.of valsartan incr.  impairm., bil.ren.art.stenos., ren.art. stenos.with sngl.kidn., aort.
       Indications: Hypertens.       with concom. inhibits.of hepat.uptake transport. OATP1B1 (rifampicin/  stenos., concom.Li/K  spar.diurets., porphyr., safety in pregn.& lactat.
                                                                           +
       (S3) TABS, 41/7.1.3/0821, 0822  ciclosporin)/ hepat.efflux transport. MRP2 (ritonavir), NSAIDs weaken   not est., safety & effect.in paed.pts.not est., lact.intol.
       716643-001: 50 mg, 30, R75,00  diuret./ antihypertens. activ, kaliuret.diuret./corticoster./ ACTH/ am-  Side effects: Headache, dizzin., orthostat.dizzin., hypotens., oed.,
       716644-001: 100 mg, 30, R90,90  photericin/carbenoxolone/penicill.G & salicylic acid.deriv.may incr.  syncope, tachycard., flush., skin reacts.incl. tox.epiderm.necrolys.,
       Dosage: Start.& maint dos: 50 mg once dly. Max. eff. attain. 3-6   hypokalaem.eff., hyponatrem. eff.of diurets.poss.intensif.by concom.   GI disturbs., swell. of extremit., musc./skelet./abdom./chest pain,
       wks.aft.initiat. May be incr.to 100 mg once dly. May be admin.with   anti-depress./antipsychots./antiepilep., thiaz. induc. hypokalaem. &   abnorm.urinat., sex.dysfunct., fatig., weakn., hyperkalaem., anaphy-
       other antihypertens.          hypomagnesaem.may favour digital.-induc.card.arrhythm., incr.incid.  lact.reacts., cough, intrahepat. cholestat.jaund., hepatit., myalg., as-
       Contraindications: Angioed.hist.link.to prev. ACE inhibit./angioten-  of hypersens. reacts.to allopurinol, incr.advers.effs. from amantadine,   then., ren.dysfunct.incl.fail., abnorm.ECG, extremit. weakn., bld.dys-
       sin recept.block., heredit./ idiopath. angioed., hypertroph.obstruct.   enhanc.hyperglycaem.eff.of diazoxide, reduc.ren.excret.of cytotox.  cras., paraesthes., restlessn., vertigo, xanthops., trans.blurr.vis., resp.
       cadiomyopathy, mod.to sev.ren.funct.impairm. (creatin. clear.&lt;30 ml/  drugs & potent. myelosuppress.effs., anticholinerg.agents incr.   distress, pancreatit., sialadenit., photosens.reacts., necrotis.angit.,
       min.)., bil.ren.artery stenos., ren.artery stenos.sngl.funct.kidn., aort.  bioavailabil., haemolyt.anaem.with methyldopa, cholestyramine/  musc.sp., interstit.nephrit., fev., electrol. imbal., glycosur., hypergly-
                +
       stenos., concom. Li/K spar.diuret., porphyr., Addisons dis.in combinat.  colestipol decr. absorpt., vit.D or Ca salts potent.rise in ser.Ca, cyclo-  caem., hyperuricaem., incr.ser.Ca lev., ac.gout attack in suscept.indiv.
       with thiazide diuret.& also sulphonam. hypersens., Li ther., pregn.,   spor. may incr.risk of hyperuricaem.& gout type complicat., alcoh.,   Special precautions: No re-challenge aft. angioed. react., hyper-
       lactat., safety & effic.in childr.not est.  barbits.& narcots.may potent.orthostat.hypotens.  sens.reacts.more likely in allergy hist./bronch.asthma, treatm.to be
       Side effects: Symptomat.hypotens., symptomat. anaem., decr.Hb,   stopp.& chang.if a woman plans/becom.pregn., adeq. contracept.
       neutropen., angioed., insomn., headache, dizzin., migraine, taste   CO EXFORGE, Novartis &  in women of child-bearing.potent., poss. dos. adjustm.to antidiab.&
       disturbs./loss thereof, palpitat., tachycard., hypotens., nas. congest.,   Amlodipine 5(10) mg, valsartan 160(160) mg, hydrochlorothiazide   antigout meds.as thiazid.elev.bld.gluc.& uric acid lev., monit.ser.Ca
       pharyngit., sinus disords., cough, URTI, GI disturbs., ac.pancreatit.,   12,5(12,5) mg.  with concom.Ca, admin.1 hr bef./4 hrs.aft. cholestyramine resin &
       incr.liv.enzyme, sev. ac.hepatotoxic., cholestas., urticar., rash, atypic.   Amlodipine 5(10) mg, valsartan 160(160) mg, hydrochlorothiazide   colestipol HCl, bld.gluc./BP monit.with concom.diazoxide, thiazide
       cutan.lymphoid infiltrat., back & leg pain, musc. cramps, myalg.,   25(25) mg.  cross placent. barr., pass. into breast milk, correct Na & vol. deplet.
       imp.ren.funct., asthen., fatig., chest pain, abdom.pain, oed./swell.,   Amlodipine 10 mg, valsartan 320 mg, hydrochlorothiazide 25 mg.  bef.init.ther., not recomm. in sev.ren./ hepat. impairm., where ren.
       thrombocytopen., vasculit., hepatit., prurit., erythroderma, photos-  Indications: Essent.hypertens.in pts. stabilis.on same dos.of in-  funct.depends on activ. of renin-angiotens.-aldosterone syst., thiaz.
       ens., arthralg., erect. dysfunct., malaise.  div.compon.   diuret. antihypertens.eff.incr.in post sympathectomy pt., progress. liv.
       Special precautions: Adeq.contracept.for women of childbear.age,   (S3) TABS. 44/7.1.3/0075, 0077, 0076, 0078, 0079  dis., hyperparathyroid.risk with mark. hypercalcaem., thiaz.incr.Mg
       hepat.impairm., monit. ser. K  conc., teratogen.in experim.animals, vol.   717631-001: 5(160)(12,5) mg, 28, R277,68  urin.excret., latent diabet.mellit.evid., monit.pts.at risk of electrol.&
                   +
       deplet., address.electrol.disturbs.in ren.impair. with/-out diab., where   717633-001: 10(160)(12,5) mg, 28, R316,11  metab. disturbs., activat./exacerbat.of SLE.
       ren.funct.depend.on renin-angiotensin-aldoster.syst.eg.sev.CHF.  717632-001: 5(160)(25) mg, 28, R277,68  Drug interactions: Poss.incr.ser. K  with K spar. diuret./ K  supplem.
                                                                                          +
                                                                                 +
                                                                                    +
       Drug interactions: Tox.bld.Li conc., NSAID’s may antagon.eff., sym-  717634-001: 10(160)(25) mg, 28, R316,10  or salt substit.contain.K , diuret. induc. hypokalaem.may accent.card.
                                                                            +
       pathomim.may reduc.eff., poss.hyperkalaem. with K -spar.diuret./K - +  719127-001: 10(320)(25) mg, 28, R373,15  dysrhythm., thiaz.diuret.decr.Ca salt excret., cholestyramine resin &
                            +
       contain. meds.or K  supplem.  Dosage: Not indic.for init.ther.of hypertens.  colestipol HCl delay/decr. hydrochlorothiaz. absorpt., incr.risk of Li
               +
                                     Pts.using same compon.dos.from separ. tabs.may be switch.to Co   toxic., non depolaris. musc.relax./pre-anaesthet.& anaesthet. effs.
       CO-DIOVAN, Novartis           Exforge tabs.contain.the same compon.dos.
       Valsartan 80(160) mg, hydrochlorothiazide 12,5(12,5) mg.  Recomm.dos: 1 tab./day.  potent., NSAID’s reduc.thiaz.diuret.eff., other antihypertens. act.
       Indications: Mild to mod.hypertens.in pts.stabil. on same dos.  Contra-indications: Sulphonamide hypersens., pregn.& lactat., an-  potent., poss.interacts.with diazoxide, alcoh./barbits.& narcots.may
       of indiv.compon.              gio-oed.with prev.ACE-inhibit./ other angiotens.recept.block., heredit./  potent orthostat. hypotens.
       (S3) TABS, 32/7.1.3/0336, 34/7.1.3/0441  idiopath. angioed., sev.hepat.impairm., Addisons dis., anur., sev. ren.  CO-MICARDIS, Ing.Pharm.
       839884-002: 80/12,5 mg, 28, R306,78   impairm.,Li ther., refract.hypokalaem., hyponatraem., hypercalcaem.,   Telmisartan 40(80) mg, hydrochlorothiaz. 12,5 (12,5) mg
       891894-005: 160/12,5 mg, 28, R224,28  symptomat. hyperuricaem., safety & effic.in childr.bel.18 yrs. not   Indications: Mild to mod.hypertens.in pts.stabilis. on same dos.
       (S3) PLUS TABS, 37/7.1.3/0225  est., safety in porphyr.not est., hypertroph. obstruct.cardiomopathy,   of indiv.compon.
       Valsartan 160 mg, hydrochlorothiazide 25 mg.  bilat.& unilat.ren.artery stenos., aort.stenos., concom.K -spar.diuret.  (S3) TABS, 35/7.1.3/0096, 0097
                                                           +
       706051-001: 160 mg/25 mg, 28, R306,80  Side-effects: Leucocytopen., thrombocytopen., allerg.reacts., an-  894614-002: 40/12,5 mg, 28, R337,98
       (S3) TABS 320/12,5, 41/7.1.3/0147  gioed., hyperglycaem., insomn., mood changes, anx., CNS effs.,   894621-009: 80/12,5 mg, 28, R337,98
       Valsartan 320 mg, hydrochlorothiazide 12,5 mg.  paraesthes., syncope, periph.neuropathy, hyperton., vis. impairm.,   Dosage: Admin.once dly. 1  stabilis.pt.on relev. dos.of indiv.compon.
                                                                              st
       710048-001: 320/12,5 mg, 28, R373,14  diplop., tinnit., palpitat., dysrhythm., bradycard., atrial fibrillat., ven-  giv.tog.then change to appropr. combinat. Cont.for at least 4-8 wks.to
       (S3) TABS 320/25, 41/7.1.3/0148  tric.tachycard., MI, flush., hypotens., vasculit., dyspn., rhinit., cough,   obt.max.eff. May be admin.with other antihypertens. meds. Do not
       Valsartan 320 mg, hydrochlorothiazide 25 mg.  GI disturbs., pancreatit., gingiv.hyperplas., hepatit., jaund., alopec.,   exceed 40/12,5 mg once dly in pts with mild to mod.hepat.impairm.
       710050-001: 320/25 mg, 28, R373,14  hyperhydros., prurit., rash, purpura, skin discolorat., photosens., ur-  Contraindications: Angioed.hist.link.to prev. ACE inhibit./angio-
       Dosage: Recomm.dos: One tab.dly. Use strength that is clinic.ap-  ticar., erythema multiforme, Stev.-John.syndr., back pain, arthralg.,   tensin recept.block., concom. aliskiren-contain.meds., heredit./idi-
       propr. Max.eff. pres. within 2-4 wks.  myalg., musc.spasm., micturit.disords., pollakiur., noctur., gynae-  opath. angioed., hypertroph.obstruct.cardiomyopathy, sev. ren.funct.
       Contraindications: Hist. of angioed.relat.to prev. ACE inhibit./ ARBs   comast., erect.dysfunct., oed., fatig., asthen., pain, malaise, chest   impairm.(creatinine clear.&lt;30 mL/min.)., bil.ren.artery stenos., ren.ar-
       ther., pregn., safety in lactat. not est., sev.hepat.impairm., bil.cirrhos.&   pain, weight incr./decr., hepat.enzyme incr., vir.infects., URTI, phar-  tery stenos.with sngl. kidn., aort.stenos., concom. Li/K spar.diuret.,
                                                                                         +
       cholestas., anuria, mod.to sev.ren.impairm., refract. hypokalaem., hy-  yngit., rhinit., decr.Hb & haematocrit., neutropen., decr.libido, abdom.  porphyr., Addison’s dis., sev.ren.impairm./anur., sulphonam.deriv.med.
       ponatraem., hypercalcaem. & symptomat. hyperuricaem., Addison’s   pain, incr.ser. creatinine/-urea/K /cholesterol & triglycer., ren. fail &   hypersens., pregn.& lactat., bil.obstruct.disords., sev.hepat.impairm.,
                                                  +
       dis., concom. renin inhibits.incl.aliskiren-contain prods., concom. Li./  impairm., pulm.oed., hypokalaem., incr.bld. lipids, hyponatraem./-  bil. cirrhos., cholestas., refract.hypokalaem./ hyponatraem./ hypercal-
       K-spar.diuretics incl.spironolactone/ triamterene/ amiloride, safety   magnesaem., hyperuricaem./ -calcaem./-glycaem., worsen.of dia-  caem.& symptomat. hyperuricaem., fruct.intol., galactosaem., con-
       & effic.in childr.not est., safety in bilat.ren.artery stenos./ren.artery   bet.metabol.state, depress., ac.angle clos. glauc., pyrex., liv.funct.  com. fluoroquinolones in mod.-sev.ren.impairm.& elderly, no data on
       stenos.to a sngl. kidn.not est., aort.stenos., hypertroph. obstruct.car-  val.incl.ser.bilirub. elev., hypochloraemic alkalosis, agranulocytos.,   safety & effic.in childr.up to 18 yrs.
       diomyopathy, heredit./ idiopath. angioed.  bone marr.fail., haemolyt./aplast.anaem.  Side effects: Common: Dizzin. Uncommon: hypokalaem., hypo-
       Side effects: Common: Incr.bld lipids, hypomagnesaem., hyperu-  Warnings and special precautions: Ren.& hepat.impairm., bil.  glycaem., anx., syncope, paraesthes., vertigo, tachycard., card.dys-
       ricaem., decr.appet., orthostat. hypotens., N&V, urticar., rash. Un-  obstruct.disords., concom.K-spar.diuret./K supplem./Ksalt substit.or   rhythm., hypotens., orthostat.hypotens., dyspn., diarrh., dry mouth,
                                                -
                                                      -
                                                           -
       common: Dehydrat., parasthes., blurr.vis., tinnit., hypotens., cough,   meds. incr. K lev., poss.adjustm.of antidiabet.dos., monit. concom. car-  flatul., back pain, musc.spasm, myalg., impot., chest pain, incr. uric
                                          +
       myalg., fatig., Rare: Thrombocytopen., purpura, photosens.react.,   bamazep.pts.for hyponatraem.reacts., teratogenic. in experim.anim.,   acid, UTI, URTI, anaem., hyperkalaem., bradycard., ren.impairm.,
       decr. libido, leucopen., agranulocytos., bone marr.fail., haemolyt.   effect.contracept.in women of child bear.age, correct.Na & vol.deplet.   ac. ren.fail., asthen. Rare: Bronchit., hyponatraem., hyperuricaem.,
       anaem., necrotis. vasculit., vasc.disords, hypercalcaem., hypergly-  bef.init.ther., no exper.in rec.ren.transpl., period. ser.electrol.determi-  depress., sleep disturbs., insomn., abnorm.vis., trans.blurr.vis., resp.
       caem., glucosur., worsen. of diabet.metabol. state, hypochloraem.  nat., SLE activat./exacerbat  distress. incl.pneumonit.& pulm.oed., abdom. pain, constipat., dys-
       alkalos., metabol. alkalos., sleep disords., depress., dysrhythm.,   Drug interactions: Ser.Li lev.incr., act.of non-depolaris.musc.relax.  peps., vomit., abnorm.hepat. funct./liv.disord., angio-oed., erythema,
       pancreatit., cholestas., jaund., tox. epiderm. necrolys., cutan.lupus-  potent., NSAID’s poss.weak. diuret.&antihypertens.activ., hypoka-  prurit., rash, incr.sweat., urticar., arthralg., leg cramps, leg pain, flu-
       erythematos.-like reacts., reactivat.of cutan.lupus erythematos. Very   laem.eff.incr. by kaliuret.diuret./corticoster./ACTH/ amphotericin/   like sympts., pain, incr.creatinine/& liv. enzymes, incr.bld.creatine
       rare: Dizzin., diarrh., arthralg. Unknown: Neutropen., hypokalaem.,   carbenoxolone/penicill.G & salicyl. acid derivat., thiazide-induc.  phosphokin., thrombocytopen., hypersens., hypoglycaem.in diab.
       hyponatraem., syncope, non-cardiogen.pulm.oed., ren.impairm./  hypokalaem/-magnesaem. favours onset of digox.-induc.card. dys-  pts., stomach discomf., eczema, med.erupt., tox. skin erupt., decr.Hb.
       fail./ disord., incr.bld.uric acid/bilirub./creatinine./urea,  abdom.   rhythm., anticholinerg.agents poss.incr. bioavailabil. of thiazid.diu-  Post-market: Pharyngit., sinusit., gastrit., aplast.-/haemolyt.anaem.,
       pain/upper abdom. pain, anx., arthrit., asthen., back pain, bronchit/  ret., haemolyt.anaem. report.with concom.use of hydrochlorothiaz.&   bone marr. depress., leukopen., neutropaen., agranulocytos., throm-
       ac.bronchit., chest pain, postur.dizzin., dyspeps., dyspn., dry mouth,   methyldopa, cholestyram.decr.absorpt.of thiazide diuret., rise in ser.  bocytopaen., allergy, anaphylact. reacts., pancreatit., stomach upset,
       epistax., erect.dysfunct., gastroenterit., headache, hyperhydros., hy-  Ca potent.by Vit.D & Ca salts, incr. hyperuricaem. risk& gout type   cholestat.-/hepatocell. jaund., photosens., exacerb./ reactiv./ activat.
       poesthes., influenza, insomn., ligam.sprain, musc.spasms/-strain,   complicat.with ciclospor., poss.hyponatraem.with carbamazepine,   SLE, sepsis incl.fatal outcome, arthros., tendon pain, sialoadenit., loss
       nas.congest., nasopharyngit., neck pain, oed., periph.oed., otit. me-  incr.allopurin.hypersens.reacts., risk of amantadine advers.eff.incr.,   of diab. control, anorex., loss of appetite, hypercholesterolaem., hy-
       dia, pain in extrem., palpitats, pharyngolaryng. pain, pollakiur., pyrex.,   hyperglycaem.eff.of diazoxide enhanc., ren.excret.of cytotox.meds.   perglycaem., restlessn., light-headedn., xanthops., ac.myop., ac.angle
       rash, sinusit., sinus congest., somnol., tachycard., URTI, UTI, vertigo,   reduc. potent.their myelosuppress.effs.  clos. glauc., vasculit./cutan.vasculit., weakn., interstit. nephrit., ren.
       vir. infects., vis.disturb., angioneurot.oed., prurit., hypersens./ allerg.  See also MDR page 540.  dysfunct., glycosur., fev., incr. triglycerides.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page145.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page141.html">141</a>&nbsp;&nbsp;&nbsp;<a href="page142.html">142</a>&nbsp;&nbsp;&nbsp;<a href="page143.html">143</a>&nbsp;&nbsp;&nbsp;<a href="page144.html">144</a>&nbsp;&nbsp;&nbsp;<a href="page145.html">145</a>&nbsp;&nbsp;&nbsp;<a href="page146.html">146</a>&nbsp;&nbsp;&nbsp;<a href="page147.html">147</a>&nbsp;&nbsp;&nbsp;<a href="page148.html">148</a>&nbsp;&nbsp;&nbsp;<a href="page149.html">149</a>&nbsp;&nbsp;&nbsp;<a href="page150.html">150</a>&nbsp;&nbsp;&nbsp;<a href="page151.html">151</a>
             </td>
             <td width="35%"><a href="page147.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page147.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
